Medical dictionary

Medical terminology normalized via MeSH, ICD-11, SNOMED CT.

62,341 terms indexed

• C575139(ethylene glycol)-poly(lactide)-poly(3-methyl-morpholine-2,5-dione)MeSH
• C587648(glycinato-kappa(2)N,O)oxidobis(peroxido-kappa(2)O,O')vanadate(V) tetrahydrateMeSH

  structure in firts source

• C578530(lysyl-phenylalanyl-phenylalanyl)3-lysineMeSH

  a cell-penetrating peptide

• C574613(methanol-kappaO)(2-methoxy-6-((2-((2-oxido-3-methoxybenzylidene)amino)benzyl)iminomethyl)phenolato-kappa4O1,N,N,O1')oxidovanadium(IV) monohydrateMeSH

  structure in first source

• C571732(methylthio)methanethiolMeSH

  structure in first source

• C585577(mu4-oxo)tetra-mu4-acetate(4-hydroxy-3,5-bis(morpholinomethyl))tetracopper(II)MeSH

  structure in first source

• C569268(octakis(2-trimethylammoniumethylthio)porphyrazinatocobalt)octaiodideMeSH
• C570780(p-(trifluoroacetamido)phenyl)ethyl 3-O-glucopyranosyl-4-O-glucopyranosyl-6-O-(2-O-(glucopyranosyl)glucopyranosyl)glucopyranosideMeSH

  a component of a potential vaccine candidate against the Gram-negative bacterium Moraxella catarrhalis

• C578541(pGlu-Gln)-CCK-8MeSH

  has potential for the treatment of obesity-diabetes

• C571847(pentane-2,4-dionato-kappa2O,O')(pyridin-2-amine-kappaN1)copper(II)MeSH

  structure in first source

• C571848(pentane-2,4-dionato-kappa2O,O')(pyrimidin-2-amine-kappaN1)copper(II)MeSH

  structure in first source

• C570388(rel 1S,3R,4R,7R)-3-(3,4-dihydroxy-4-methylpent-3-enyl)-1, 3, 7-trimethyl-2-oxabicyclo(2, 2,1)heptaneMeSH

  from Trichoderma atroviride; structure in first source

• C570387(rel 1S,3R,4R,7R)-3-(5-hydroxy-4-methylpent-3-enyl)-1, 3, 7-trimethyl-2-oxabicyclo(2, 2,1)heptaneMeSH

  from Trichoderma atroviride; structure in first source

• C586275(thiazol-2-yl)hydrazineMeSH

  structure in first source

• C585107(thiolan-2-yl)diphenylmethanolMeSH

  structure in first source

• C560410(valyl-glutamyl-leucyl-prolyl-prolyl-prolyl)3MeSH

  a cell-penetrating peptide

• C585814071031B compoundMeSH

  also a norepinephrine reuptake inhibitor; structure in first source

• C5838711'',7''-bis(4-cyanobiphenyl-4'-yl)heptaneMeSH

  structure in first source

• C5612121',2'-didehydro-7,8-dimethoxyplatydesmineMeSH

  alkaloid from Dictamnus dasycarpus; structure in first source

• C5694431',3'-dihydrospiro(fluorene-9,2'-perimidine)MeSH

  structure in first source

• C5777261',5-dimethoxy-3,5'-dimethyl-2,3'-oxybiphenyl-1,2'-diolMeSH

  from Preussia typharum; structure in first source

• C5877661'-(3-(3,4-dichlorophenyl)prop-2-en-1-yl)-2H,5H-spiro(imidazolidine-4,3'-indole)-2,2',5(1'H)-trioneMeSH

  inhibits TRPV1 channels; structure in first source

• C5841991'-(4-methoxyphenyl)-2'-(furan-2-carbonyl)-1',2',5',6',7',7a'-hexahydrospiro(indoline-3,3'-pyrrolizin)-2-oneMeSH

  structure in first source

• C5831061'-hydroxymethyl-phenyl 4-hydroxy-3-(4'-hydroxybenzyl) benzyl etherMeSH

  isolated from the rhizomes of Gastrodia elata; structure in first source

• C5726471'-oxomethyleugenolMeSH

  structure in first source

• C5726481'-sulfooxymethyleugenolMeSH

  structure in first source

• C5883871(5)-guaiene-11-O-(3'-angeloxy-6'-deoxy)glucopyranosideMeSH

  an NSAID; isolated from Pittosporum undulatum; structure in first source

• C5687261, 2,3,7,8,12,13,17,18-octaethyl-5,10-diphenylporphyrinMeSH

  structure in first source

• C5685481,1'-(ethane-1,2-diyl)bis(3-chloro-4-(3,4-dimethoxyphenyl)azetidin-2-one)MeSH

  structure in first source

• C5783151,1'-biphenyl-4-thiolMeSH

  structure in first source

• C5765691,1'-dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanineMeSH
• C5740201,1'-dioctadecyl-3,3,3',3'-tetramethylindotricarbocyanineMeSH
• C5820731,1'-dioleyl-3,3,3',3'-tetramethylindocarbocyanineMeSH
• C5757341,1'-ethynebenzene-3,3',5,5'-tetracarboxylate-Zinc(II)MeSH

  structure in first source

• C5839081,1'-sulfonylbis(2-(methylthio)ethane)MeSH

  reduction product of beta-lyase metabolites of sulfur mustard; structure in first source

• C5757151,1,1,3,3,3-hexafluoro-2-(2-fluoro-4'-((4-(pyridin-4-ylmethyl)piperazin-1-yl)methyl)-(1,1'-biphenyl)-4-yl)propan-2-olMeSH

  a retinoic acid receptor-related orphan receptor modulator; structure in first source

• C5820151,1,1-tribromo-2,2-bis(3,4-dimethoxyphenyl)ethaneMeSH

  structure in first source

• C5857471,1,1-trifluoro-2-(4-(2-((3-methylmorpholino)methyl)-4-(thiophen-2-ylsulfonyl)piperazin-1-yl)phenyl)propan-2-olMeSH

  disrupts interactions between glucokinase and glucokinase regulatory protein; structure in first source

• C5875961,1,1-trifluoro-6-(naphthalen-2-yl)hexan-2-oneMeSH

  inhibits Group VIA Ca(II)-independent phospholipase A2; structure in first source

• C5819111,1,1-tris-(diphenylphosphinomethyl)ethaneMeSH

  structure in first source

• C5852331,1,2,2,3,3,4-heptafluorocyclopentaneMeSH

  structure in first source

• C5618831,1,3,3-tetrabromo-2-heptanoneMeSH

  has antibacterial activity; isolated from the red alga Bonnemaisonia hamifera

• C5682861,1,3,3-tetramethyl-2,3-dihydro-2-azaphenalen-2-yloxylMeSH

  an EPR oximetry probe; structure in first source

• C5816811,1,3,4-tetrahydro-6-(1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl)quinazolin-2,4-dioneMeSH
• C5737211,1,6-trimethyl-1,2-dihydronaphthaleneMeSH

  structure in first source

• C5706751,1-bis(1-methyl-2,3,4,5-tetraphenyl-1-silacyclopentadiene)MeSH

  structure in first source

• C5834651,1-dichloro-1-nitroethaneMeSH
• C5619271,1-dichloro-4-ethyl-5-(4-nitrophenyl)hexan-2-oneMeSH

  isolated from Nocardia; structure in first source

• C5718071,1-diethoxycyclohexaneMeSH

  structure in first source

• C5877031,1-difluorostyreneMeSH

  structure in first source